Pyruvate carboxylase deficiency
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
Pyruvate carboxylase deficiency is an inherited disorder that causes lactic acid and other potentially toxic compounds to accumulate in the blood. High levels of these substances can damage the body's organs and tissues, particularly in the nervous system.
اختيارات الفيديو لـ الحالات الوراثيةمكتبة الفيديو
الوصف
Pyruvate carboxylase deficiency is an inherited disorder that causes lactic acid and other potentially toxic compounds to accumulate in the blood. High levels of these substances can damage the body's organs and tissues, particularly in the nervous system.
Researchers have identified at least three types of pyruvate carboxylase deficiency, which are distinguished by the severity of their signs and symptoms. Type A, which has been identified mostly in people from North America, has severe symptoms that begin in infancy. Characteristic features include developmental delay and a buildup of lactic acid in the blood (lactic acidosis). Increased acidity in the blood can lead to vomiting, abdominal pain, extreme tiredness (fatigue), muscle weakness, and difficulty breathing. In some cases, episodes of lactic acidosis are triggered by an illness or periods without food (fasting). Children with pyruvate carboxylase deficiency type A typically survive only into infancy or early childhood.
Pyruvate carboxylase deficiency type B has life-threatening signs and symptoms that become apparent shortly after birth. This form of the condition has been reported mostly in Europe, particularly France. Affected infants have severe lactic acidosis, a buildup of ammonia in the blood (hyperammonemia), and liver failure. They experience neurological problems including weak muscle tone (hypotonia), abnormal movements, seizures, and coma. Infants with this form of the condition usually survive for less than 3 months after birth.
A milder form of pyruvate carboxylase deficiency, sometimes called type C, has also been described. This type is characterised by slightly increased levels of lactic acid in the blood and minimal signs and symptoms affecting the nervous system.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Ataxia with lactic acidosis, type II
Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency
Leigh syndrome due to pyruvate carboxylase deficiency
PC deficiency
Pyruvate carboxylase deficiency disease
Type II ataxia with lactic acidosis
Related patient information and medicines

Patient information leaflet
فقر الدم
Conditions where there are haemoglobin abnormalities such as sickle cell anaemia Sickle cell disease or thalassaemia Thalassaemi... And problems with the chemicals (or enzymes) that help the blood cell do its job, such as نقص G6PD و pyruvate kinase deficiency. Another set of conditions may arise from your immune system attacking your own.

Patient information leaflet
سوء الامتصاص المعوي
Gastrointestinal malabsorption syndrome means a failure to fully absorb digested foods from the gut (bowel) into your body. There are many different causes. Prolonged intestinal malabsorption may cause problems because of a lack of carbohydrates, proteins, fats, minerals and vitamins that are essential to keep you healthy. The treatment will.

Patient information leaflet
هل يمكنني تناول فيتامين B2 وفيتامين C معًا؟
Important precautions Kidney stones (oxalate) High doses of vitamin C can increase the amount of oxalate in your urine, which significantly raises the risk of developing kidney stones, especially if you have had them before. G6PD deficiency If you have a G6PD deficiency (a genetic enzyme condition), high doses of vitamin C can cause your red blood.

Patient information leaflet
هل يمكنني تناول فيتامين ب12 وفيتامين ج معًا؟
نقص G6PD Very high doses of فيتامين C can cause oxidative stress and lead to the breakdown of red blood cells (haemolysis) in individuals with نقص إنزيم G6PD. لدينا مدقق تفاعلات الأدوية helps you check whether your prescriptions, over-the-counter medicines, and المكملات الغذائية يكون آمن to take together. Disclaimer This information is.

Patient information leaflet
هل يمكنني تناول فيتامين ب المركب وفيتامين ج معًا؟
It is best to take your vitamins with water rather than tea or coffee. Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps تعتقد check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
هل يمكنني تناول فيتامين سي وفيتامين د معًا؟
Taking it on an empty stomach may reduce its effectiveness. Using other medicines Taking multiple medicines. Our مدقق تفاعلات الأدوية helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do about them..
قراءة إضافية ومراجع
- Pyruvate carboxylase deficiency; MedlinePlus, National Library of Medicine.
- Carbone MA, MacKay N, Ling M, Cole DE, Douglas C, Rigat B, Feigenbaum A, Clarke JT, Haworth JC, Greenberg CR, Seargeant L, Robinson BH. Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. Am J Hum Genet. 1998 Jun;62(6):1312-9. doi: 10.1086/301884.
- De Meirleir L. Disorders of pyruvate metabolism. Handb Clin Neurol. 2013;113:1667-73. doi: 10.1016/B978-0-444-59565-2.00034-4.
- Garcia-Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray JM. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol. 2006 Jan;59(1):121-7. doi: 10.1002/ana.20709.
- Marin-Valencia I, Roe CR, Pascual JM. Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis. Mol Genet Metab. 2010 Sep;101(1):9-17. doi: 10.1016/j.ymgme.2010.05.004. Epub 2010 Jun 9.
- Monnot S, Serre V, Chadefaux-Vekemans B, Aupetit J, Romano S, De Lonlay P, Rival JM, Munnich A, Steffann J, Bonnefont JP. Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency. Hum Mutat. 2009 May;30(5):734-40. doi: 10.1002/humu.20908.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 Aug 2006 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

